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Abstract: Modic type 1 changes (MC1) are painful vertebral bone marrow lesions frequently found in
patients suffering from chronic low-back pain. Marrow fibrosis is a hallmark of MC1. Bone marrow
stromal cells (BMSCs) are key players in other fibrotic bone marrow pathologies, yet their role in MC1
is unknown. The present study aimed to characterise MC1 BMSCs and hypothesised a pro-fibrotic role
of BMSCs in MC1. BMSCs were isolated from patients undergoing lumbar spinal fusion from MC1 and
adjacent control vertebrae. Frequency of colony-forming unit fibroblast (CFU-F), expression of stem
cell surface markers, differentiation capacity, transcriptome, matrix adhesion, cell contractility as well as
expression of pro-collagen type I alpha 1, ฀-smooth muscle actin, integrins and focal adhesion kinase (FAK)
were compared. More CFU-F and increased expression of C-X-C-motif-chemokine 12 were found in MC1
BMSCs, possibly indicating overrepresentation of a perisinusoidal BMSC population. RNA sequencing
analysis showed enrichment in extracellular matrix proteins and fibrosis-related signalling genes. Increases
in pro-collagen type I alpha 1 expression, cell adhesion, cell contractility and phosphorylation of FAK
provided further evidence for their pro-fibrotic phenotype. Moreover, a leptin receptor high expressing
(LEPRhigh) BMSC population was identified that differentiated under transforming growth factor beta
1 stimulation into myofibroblasts in MC1 but not in control BMSCs. In conclusion, pro-fibrotic changes
in MC1 BMSCs and a LEPRhigh MC1 BMSC subpopulation susceptible to myofibroblast differentiation
were found. Fibrosis is a hallmark of MC1 and a potential therapeutic target. A causal link between the
pro-fibrotic phenotype and clinical characteristics needs to be demonstrated.
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Abstract
Modic type 1 changes (MC1) are painful vertebral bone marrow lesions frequently found in patients suffering 
from chronic low-back pain. Marrow fibrosis is a hallmark of MC1. Bone marrow stromal cells (BMSCs) are 
key players in other fibrotic bone marrow pathologies, yet their role in MC1 is unknown. The present study 
aimed to characterise MC1 BMSCs and hypothesised a pro-fibrotic role of BMSCs in MC1.
 BMSCs were isolated from patients undergoing lumbar spinal fusion from MC1 and adjacent control 
vertebrae. Frequency of colony-forming unit fibroblast (CFU-F), expression of stem cell surface markers, 
differentiation capacity, transcriptome, matrix adhesion, cell contractility as well as expression of pro-collagen 
type I alpha 1, α-smooth muscle actin, integrins and focal adhesion kinase (FAK) were compared.
 More CFU-F and increased expression of C-X-C-motif-chemokine 12 were found in MC1 BMSCs, possibly 
indicating overrepresentation of a perisinusoidal BMSC population.
 RNA sequencing analysis showed enrichment in extracellular matrix proteins and fibrosis-related 
signalling genes. Increases in pro-collagen type I alpha 1 expression, cell adhesion, cell contractility and 
phosphorylation of FAK provided further evidence for their pro-fibrotic phenotype. Moreover, a leptin 
receptor high expressing (LEPRhigh) BMSC population was identified that differentiated under transforming 
growth factor beta 1 stimulation into myofibroblasts in MC1 but not in control BMSCs.
 In conclusion, pro-fibrotic changes in MC1 BMSCs and a LEPRhigh MC1 BMSC subpopulation susceptible 
to myofibroblast differentiation were found. Fibrosis is a hallmark of MC1 and a potential therapeutic target. 
A causal link between the pro-fibrotic phenotype and clinical characteristics needs to be demonstrated.
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bFGF  basic fibroblast growth factor
BMI  body mass index
BMSCs  bone marrow stromal cells
BSA  bovine serum albumin
CD  cluster of differentiation
CFU-F  colony-forming unit fibroblast
COL1A1 collagen type I alpha 1




MC are vertebral bone marrow lesions visualised by 
MRI that occur around a degenerated intervertebral 
disc (Modic et al., 1988). Of the three interconvertible 
types of MC, MC1 has the highest association with 
LBP (Kääpä et al., 2012; Nguyen et al., 2015). LBP 
patients with MC1 report a higher frequency and 
duration of LBP episodes, seek care more often and 
have a higher risk for no improvement in pain and 
function (Chung et al., 2004; Jensen et al., 2008; Jensen 
et al., 2014; Schistad et al., 2014; Sørile et al., 2012). 
Larger lesions are more painful and have a positive 
predictive value for discography concordant pain of 
up to 100 % (Järvinen et al., 2015; Weishaupt et al., 
2001). In contrast to disc herniation, where nerve 
compression causes back and leg pain, MC pain 
originates from the endplate and vertebra (Fields et 
al., 2014; Lotz et al., 2013; Ohtori et al., 2006).
 Despite the high clinical and socioeconomic 
importance, MC1 pathophysiology is largely 
unknown. Only a few studies have investigated 
human surgical MC1 bone marrow tissue. In Michael 
Modic's original paper, he described MC1 bone 
marrow based on three biopsies as a fibrovascular 
granulation tissue (Modic et al., 1988). Perilli et al. 
(2015) investigated nine MC1 biopsies by histology 
and micro-CT and concluded that MC1 had a high 
bone turnover possibly due to inflammation. In 
a cross-sectional analysis of MC1 bone marrow 
aspirates and of adjacent discs, Dudli et al. (2017) 
found pro-fibrotic changes (i.e. increased COL1A1 
expression) in MC1 and a pro-fibrotic and pro-
inflammatory cross-talk between MC1 bone marrow 
and the adjacent disc. In summary, these studies 
have identified fibrosis, inflammation and high bone 
turnover as the pathophysiological hallmarks of MC1. 
However, the fibrotic mechanism in MC1 remains 
largely unknown.
 BMSCs are key regulators of bone marrow 
inflammation, fibrosis and bone turnover (Kondo et 
al., 2001; Schneider et al., 2017; Ziegler et al., 2016). 
BMSCs fulfil the criteria for MSCs (Dominici et al., 
2006): they express CD73, CD90, CD105 but not CD14, 
CD19, CD34, CD45 and HLA-DR; they form CFU-F 
on plastic dishes and can differentiate into adipocytes, 
osteoblasts and chondrocytes. Primary BMSCs are a 
heterogeneous population and their reported markers 
include LEPR, CD54, CD106, CD140a, CD146, CD271, 
CXCL12, nestin and NG2 (El Agha et al., 2017a; 
Decker et al., 2017). Expression of specific markers 
has been associated with their bone marrow niche 
localisation. BMSCs from the endosteal niche are 
CD146− while BMSCs from the vascular niche express 
CD106, CD146, CD271, CXCL12 and NG2 (Barilani 
et al., 2018; Tormin et al., 2011). Within the vascular 
niche, periarteriolar and perisinusoidal BMSCs can 
be distinguished based on their expression profile. 
Nestin expression is higher in periarteriolar BMSCs, 
COL4A5 collagen type IV alpha 5
CXCL12 C-X-C-motif-chemokine 12
DEG  differentially expressed gene
ECM  extracellular matrix
EDTA  ethylenediaminetetraacetic acid
ELISA  enzyme-linked immunosorbent
   assay
EMT  epithelial-myofibroblast
   transformation
FACS  fluorescence-activated cell sorting
FAK  focal adhesion kinase
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FN1  fibronectin
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GO  gene ontology
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while LEPR and CD106 is higher in sinusoidal 
BMSCs (El Agha et al., 2017a; Jacobsen et al., 1996). 
Expression of specific markers has also been linked 
to pathological conditions. For example, perivascular, 
LEPR-expressing BMSCs have been identified as the 
cellular origin of collagen-producing myofibroblasts 
in bone marrow fibrosis (Decker et al., 2017). These 
cells are profoundly dysregulated as evidenced by 
myelofibrosis, osteosclerosis and neoangiogenesis. 
Perivascular BMSCs are pericyte-like cells and Notch 
signalling promotes their PMT. Notch signalling is 
an important pro-fibrotic pathway affecting BMSC 
proliferation and differentiation (Azizidoost et al., 
2015; Dong et al., 2010; Wang et al., 2019).
 Despite the important role of BMSCs in fibrosis, 
their role in MC1 is unknown. To gauge the role of 
BMSCs in MC1, MC1 BMSCs were compared to intra-
patient control BMSCs from chronic LBP patients 
undergoing spinal fusion. The aim of the study was 
to identify and characterise potential pro-fibrotic 
attributes of MC1 BMSCs.
Material and Methods
The study was conducted in accordance with the 
Declaration of Helsinki and approved by the local 
Ethics Commission (#2017-00761; approved June 
05, 2017). Chemicals were purchased from Sigma-
Aldrich if not stated otherwise.
Study subjects
Informed consent was obtained from each subject. 
The study included 14 patients undergoing lumbar 
spondylodesis at the Balgrist University Hospital 
between April 2018 and July 2020. Inclusion criteria 
were (i) spinal fusion at level of MC1 with a large 
enough MC1 lesion that a pedicle screw came to lie 
into the MC1 lesion, (ii) a second pedicle screw in 
a vertebral bone marrow region without MC from 
the same patient (Fig. 1). Exclusion criteria were 
applied based on past medical history and were 
infectious diseases, malignancies, prior instrumented 
back surgery, rheumatic markers e.g. HLA, auto-
antibodies, juvenile scoliosis and leg pain greater 
than back pain on VAS. Patients were identified pre-
operatively based on T1w, T2w and STIR lumbar 
MRI. Subjects completed a 10-item ODI questionnaire 
and indicated intensity of back and leg pain on a 
10 cm VAS (VASback and VASleg, respectively). 
Patient demographics are summarised in Table 1.
 Magnetic resonance images were retrospectively 
analysed by a radiologist with > 12 years of experience 
including > 5 years in musculoskeletal radiology. 
The MRI sequences available were sagittal T1w 
and sagittal T2w images, sagittal STIR, coronal T2w 
images, intra-operative X-ray as well as post-operative 
T1w and T2w sagittal images. Mean difference from 
date of surgery to MRI acquisition was 41.9 ± 29.8 d. 
The location of the Jamshidi needle tip during 
aspiration (or pedicle screw tip if no intraoperative 
X-ray were available) was determined and MC type 
(no MC, MC1, MC2, MC3) and extent ( < 50 %, > 50 % 
of vertebral body height) at needle tip location was 
rated. Total endplate score (0-6) (Rajasekaran et al., 
2008) and Pfirmann grade of adjacent disc (0-5) were 
compared using paired Wilcoxon tests.
Bone marrow aspirates and BMSC culture
Spondylodesis requires the insertion of pedicle 
screws into the vertebral bodies. Using the pedicle 
screw trajectories, bone marrow aspirates were taken 
before screw insertion using a Jamshidi needle. Two 
aspirates were taken from each patient: a MC1 and 
an intra-patient control aspirate (Fig. 1). Proper 
positioning of the Jamshidi needle was key. In pre-
operative discussions with the surgeons and with 
intra-procedural radiographic guidance, proper 
needle position was ensured. Surgeons were advised 
to aspirate 2.5-3.5 mL bone marrow immediately after 
reaching the target depth. Aspirates were taken with 
a 10 mL syringe and transferred within 2 min into K2-
EDTA tubes (BD Bioscience). Bone marrow aspirates 
were centrifuged at 700 ×g and 4 °C for 15 min. Bone 
marrow fat and plasma were removed and red blood 
cells were lysed.
Fig. 1. MC1 at L5/S1. Pre-operative sagittal T2w MRI (left), intraoperative sagittal X-ray during harvesting 
of MC1 aspirate (middle) and intra-patient control aspirate (right). Red and blue circle indicate location of 
MC1 and control aspirate, respectively.
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 BMSCs were isolated by plastic adherence 
(Dominici et al., 2006; Hoch and Leach, 2015). 
30 × 106 cells were resuspended in growth medium 
[αMEM without nucleosides (Gibco™), 50 U/
mL P/S (Gibco), 10 mmol/L HEPES (Gibco), 10 % 
heat-inactivated FCS and 2.5 ng/mL human bFGF 
(PeproTech)] and seeded in T75 flasks. Cells were 
incubated at 37 °C and 5 % CO2 with medium change 
every 3-4 d. For all assays, BMSCs from passage 3-5 
were used (Table 2). MC1 BMSCs and control BMSCs 
were used at the same passage for each patient. The 
performed assays for each patient are indicated in 
Table 1.
Assay 1 and 2: flow cytometric characterisation
In assay 1, stem cell surface markers CD105, CD73, 
CD90, CD45, CD34, CD14 and CD19 were stained for 
45 min at room temperature (Table 3), washed with 
FACS buffer (PBS without Ca2+ and Mg2+, 1 % FCS) and 
analysed using a BD LSRFortessa™ Flow Cytometer. 
Single measures of MC1 and control BMSCs were 
performed. Ratio of CD73+, CD90+, CD105+, CD45−, 
CD34−, CD14−, CD19− cells was calculated using 
FlowJo (version 10.7.1) and compared between MC1 
and control BMSCs by paired t-test.
 In assay 2, for intracellular epitopes (nestin, 
CXCL12) measurement, cells were permeabilised 
using BD FACS™ Permeabilizing Solution 2 
according to manufacturer’s protocol. Cells were 
stained either for CD54, CD106, CD140a, CD146, 
CD271, LEPR, NG2, CXCL12 or nestin for 45 min 
at room temperature (Table 3), washed with FACS 
buffer and analysed using BD LSRFortessa™ Flow 
Cytometer. Single measures of MC1 and control 
BMSCs were performed. The non-normal distributed 
difference of MC1 and control MFI was tested against 
null hypothesis (µ0 = 0) by Wilcoxon test. Pearson 
correlation coefficients were calculated between 
different markers.
Assay 3: differentiation capacity
Adipogenesis was induced in sextuplicate in 80-
90 % confluent BMSC layers in 24-well plates with 
inductive medium (αMEM no nucleosides medium, 
50 U/mL P/S, 10 mmol/L HEPES, 10 % FCS, 5 µg/
mL insulin, 10−7 mol/L dexamethasone, 0.5 mmol/L 
isobutylmethylxanthine, 60 µmol/L indomethacin). 
Inductive medium was changed every 3 d. BMSCs 
were fixed when MC1 and control cells showed 
fat droplets (after 14-21 d, same day for MC1 and 
control). Lipid droplets were stained with oil red O 
solution. After rinsing with 50 % ethanol and distilled 
water, oil red O was dissolved in 100 % 2-propanol 
and absorbance was read at 500 nm. Median 
absorbances of sextuplicate were calculated. MC1 
was normalised to control (100 %) and tested against 
null hypothesis (µ0 = 100 %) using one sample t-test.
 Osteogenesis was induced in sextuplicate of 
100 % confluent BMSC layers in 24-well plates with 
inductive medium (αMEM no nucleosides medium, 
50 U/mL P/S, 10 mmol/L HEPES, 10 % FCS, 10−7 mol/L 
dexamethasone, 10 mmol/L β glycerophosphate, 
50 µmol/L L-ascorbic acid 2-phosphate). Inductive 
medium was changed every 3 d. BMSCs were fixed 
after 21 to 28 d (same day for MC1 and control) and 
stained with a 2 % alizarin red solution. The staining 
was dissolved with 10 % cetylpyridiniumchloride 
solution and absorbance was read at 570 nm. Median 
absorbances were calculated. MC1 was normalised 
to control (100 %) and tested against null hypothesis 
(µ0 = 100 %) using one sample t-test.
 Chondrogenesis was induced in BMSC pellets 
(0.3 × 106 cells) seeded in sextuplicate on 96-
well ultra-low attachment U-bottom plates with 
Assay Test parameter Method n
1 Stem cell marker expression Flow cytometry 6





Adipogenic differentiation LEPRhigh 3
4 Incidence of BMSCs CFU-F 6
5 Gene expression Bulk RNA sequencing 4
6 Gene expression RT-qPCR 5-9
7 Pro-collagen type I alpha 1 synthesis ELISA 6
8 Collagen contraction In vitro functional assay 7
9 α-SMA, FAK/p-FAK synthesis Western blot 7-10
10 Adhesion capacity In vitro functional assay 8-11
11
TGF-β1 stimulated gene expression RT-qPCR 5-7
TGF-β1 stimulated α-SMA synthesis Western blot 5
TGF-β1 stimulated collagen contraction In vitro functional assay 5
TGF-β1 stimulated α-SMA synthesis (LEPRhigh) Western blot 3-4
12 Sorting of LEPRhigh BMSCs Fluorescence activated cell sorting 3-4
Table 2. BMSCs from MC1 and control bone marrow were characterised using 12 different assays.
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inductive medium (DMEM high glucose, 50 U/mL 
P/S, 10 mmol/L HEPES, 10−7 mol/L dexamethasone, 
1 % insulin-transferrin-sodium selenite medium 
supplement, 1  % non-essential amino acid, 
0.05 mmol/L L-ascorbic acid-2-phosphate, 10 ng/mL 
recombinant human TGF-β1). Medium was changed 
every 3 d. Cells were fixed after 28 d. 2 to 3 pellets 
were pooled and digested overnight with papain 
(60 °C, 125 ug/mL dissolved in 5 mmol/L L-cysteine 
HCl, 5 mmol/L Na-citrate, 150 mmol/L NaCl, 
5 mmol/L EDTA, pH 6.0). DNA was quantified using 
DNA quantification Kit according to manufacturer’s 
protocol. GAG was quantified using 1,9-dimethyl-
methylene blue assay (Enobakhare et al., 1996). 
Median GAG/DNA of control samples was set 
to 100 %. Relative GAG/DNA of MC1 samples 
was calculated and tested against null hypothesis 
(µ0 = 100 %) using one sample t-test.
Assay 4: incidence of BMSCs (CFU-F)
After red blood cell lysis of freshly harvested bone 
marrow aspirates, 5-10 × 106 nucleated bone marrow 
cells were seeded on a 60 cm2 Petri dish in growth 
medium and cultured for 10-15 d. Cells were fixed 
and colonies were stained with 0.1 % crystal violet 
solution, imaged and manually counted (ImageJ 
v1.52p). Single measures of MC1 and control BMSCs 
were performed. Colony number from control bone 
marrow was set as 100 %. Relative MC1 colony count 
was calculated and tested against null hypothesis 
(µ0 = 100 %) using one sample t-test.
Assay 5: bulk RNA sequencing
RNA was isolated from BMSCs harvested at 90-
100 % confluency using miRNeasy Mini Kit (Qiagen) 
according to the manufacturer’s protocol. The library 
was prepared with an input of 150 ng total RNA 
using the TruSeq® Stranded total RNA preparation 
kit (Illumina). Ribosomal RNA was depleted using 
the Ribo-Zero Gold kit (Illumina). Libraries were 
sequenced using the HiSeq 4000 (Illumina) sequencer 
(paired-end sequencing, 151 cycles, > 40 million 
reads per sample). The quality of data readings was 
checked using Fast QC. Adaptor sequences at the 3’ 
ends were removed and 4 bases at each end were 
trimmed with Trimmomatic (v0.36). Readings with 
> 30 nt were analysed. Readings were mapped to the 
reference genome hg38 (STAR; 2.6.0c), counted using 
FeatureCounts and statistical analysis was performed 
using EdgeR (v3.22.1). Genes were considered to 
be differentially expressed for p < 0.01 and Log2 
fold change > ± 0.5. GO enrichment analysis was 
performed using Metacore (version 19.4) and DAVID 
(version 6.8) databases. GSEA was carried out with 
the GSEA software v4.1.0 (UC San Diego and Broad 
Institute, San Diego, CA, USA) (Subramanian et al., 
2005) using signal to noise as gene ranking metric 
and 1,000 random permutations of the gene set. The 
analysis was performed with all hallmark gene sets 
from the Molecular Signatures Database (MSigDB) 
v7.1 (Subramanian et al., 2005) and for a specific 
fibrosis gene set (Wohlfahrt et al., 2019). Gene sets 
were considered to be enriched with FDR q-value 
< 0.1. Enrichment map visualisation was carried out in 
the GSEA software v4.1.0 using GSEA result of c2.cp.
reactome with p < 0.01, FDR q-value < 0.1 and network 
was visualised in Cytoscape version 3.8.0 using an 
overlap coefficient of 0.5. RNA sequencing data is 
available at the European Nucleotide Archive (ENA) 
at EMBL-EBI under accession number PRJEB39993 
(Web ref. 1).
Assay 6: RT-qPCR
RNA was isolated as described above. Reverse 
transcription and qPCR were done according to 
manufacturer’s protocol (Labgene, Châtel-Saint-
Denis, Switzerland). Briefly, cDNA was synthesised 
using the SensiFAST cDNA Synthesis Kit using 
100 ng RNA. Gene expression was quantified using 
Mic Real-Time PCR system (Labgene) and the 
SensiFAST™ SYBR® No-ROX Kit (Table 4) adding 
2.5 % input of total cDNA. 40 cycles of 5 s 95 °C, 
20 s 60 °C, 10 s 72 °C were run followed by melting 
curve analysis. Samples were measured in technical 
duplicates and melting curves were analysed to 
ensure amplification of single products. For the 
COL4A5 (Hs01012435_m1), TaqMan probes were 
used with SensiFAST Probe No-ROX Kit. 50 cycles 
of 5 s 95 °C, 40 s 60 °C were run and single measures 
were performed. Gene expression was quantified 
using the ΔΔCq method with HPRT1 as a reference 
gene. ΔΔCq values were tested against the null 
hypothesis (µ0 = 0) with one sample t-test.
Assay 7: ELISA for pro-collagen type I alpha 1
BMSCs were grown in duplicates to 90-100 % 
confluency in growth medium and cultured for 48 h 
Table 3. Conjugated antibodies used for flow 
cytometry. PE: phycoerythrin; FITC: fluorescein; 
PerCP: peridinin-chlorophyll-protein; BV: brilliant 









CD54 Thermo Fisher Scientific PE
CD106 Biolegend PE
CD140a Thermo Fisher Scientific PE
CD146 Thermo Fisher Scientific PE
CD271 Biolegend PE
LEPR Milteny Biotech APC-Vio770
NG2 Thermo Fisher Scientific PE
CXCL12 R&D Systems PE
Nestin Biolegend PE
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in starvation medium with 1 % FCS. After medium 
change, medium was conditioned for 24 h. A 75-fold 
dilution was assayed for pro-collagen type I alpha 1 
using Human Pro-Collagen I alpha 1 DuoSet (R&D 
Systems) according to manufacturer’s protocol. 
Samples were measured in technical duplicates. 
The non-normally distributed concentrations were 
compared between MC1 and control using paired 
Wilcoxon test.
Assay 8: collagen contraction assay
BMSCs (0.2 × 106 in 1.2 mL starvation medium) were 
mixed with 600 µL of 3 mg/mL rat tail collagen I 
(Corning), 0.1 % acetic acid and 10 mmol/L NaOH. 
500 µL of this mixture was added to a 24 well ultra-
low attachment plate, covered with 500 µL starvation 
medium and incubated at 37 °C and 5 % CO2. Samples 
were measured in biological triplicates. Gels were 
imaged after 24 h and surface area was measured 
using Image J (version 1.52p). Size of MC1 BMSC 
gels was normalised to control BMSC gels (100 %) 
of the same patient tested against null hypothesis 
(µ0 = 100 %) using one sample t-test.
Assay 9: Western blot
Confluent layers of BMSCs were lysed in Laemmli 
buffer. Proteins were separated with SDS-PAGE on 
10 % polyacrylamide gels and transferred to PVDF 
membranes using the Trans-Blot® Turbo™ Transfer 
System (BioRad). Membranes were blocked for 3 h 
with 5 % (w/v) non-fat dry milk (or 3 % BSA in case 
of p-FAK) in TBS with 0.1 % (v/v) Tween® 20 and 
incubated overnight in 3 % (w/v) BSA in TBS with 
0.1 % (v/v) Tween® 20 and with primary antibodies 
from Cell Signaling Technologies: 1 : 1,000 rabbit 
anti-human β-actin (#8457), 1 : 1,000 rabbit anti-
human FAK (#3285), 1 : 1,000 rabbit anti-human 
p-FAK (Tyr397) (#3283), 1 : 1,000 rabbit anti-human 
integrin β1 (#4706); or from Lucerna: 1 : 2,000 rabbit 
anti-human α-SMA (GTX100034). Membranes were 
incubated with HRP-conjugated goat anti-rabbit 
immunoglobulin G (IgG) (7074, Cell Signaling 
Technologies, 1 : 3,000) and chemiluminescence was 
detected using the UltraScence Pico Ultra Western 
Substrate (Bio-Helix, Keelung City, Taiwan) on a 
BioRad VersaDoc. Single measures of MC1 and 
control BMSCs were performed. Signal intensities 
Table 4. Primer pairs used for SYBR green RT-qPCR. ITGA: integrin subunit alpha; ITGB: integrin subunit 
beta.
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of bands were determined using Image J (version 
1.52a). Band intensities of α-SMA and FAK were 
normalised to β-actin and p-FAK was normalised to 
FAK. Percentages of MC1 and control intensities were 
compared by paired Wilcoxon test.
Assay 10: adhesion assay
BMSC adhesion to fibronectin-coated, collagen 
I-coated and uncoated surface was assessed. 96-well 
plates were coated overnight at 4 °C using 16 µg/
mL fibronectin or 0.75 mg/mL collagen I (Corning). 
Fibronectin- and collagen I-coated wells were blocked 
for non-specific binding with 1 % heat-inactivated 
BSA for 1 h at 37 °C. 2,500 cells/well were seeded 
in sextuplets. After 15 min, 30 min and 4 h, cell 
suspension was removed and non-adherent cells 
were washed away with PBS. Adherent cells were 
fixed using 4 % neutral buffered formalin and stained 
with Hoechst 33342 (ThermoFisher Scientific). 4 
images per well were taken at predefined spots using 
a Nikon Eclipse Ti2 upright brightfield microscope. 
Cells were counted manually using ImageJ. Cell 
counts at 15 min and 30 min were normalised to the 
respective 4 h count. Percentage increase of adherent 
MC1 and control BMSCs between 15 min (settling 
time) and 30 min were calculated and compared 
using a paired t-test.
Assay 11: TGF-β1 stimulation
The capacity of MC1 and control BMSCs to differentiate 
into myofibroblast was tested using TGF-β1 
stimulation [24 h with 10 ng/mL recombinant human 
Fig. 2. Population and stemness characterisation of MC1 BMSCs. (a) MC1 BMSCs had a reduced 
adipogenic differentiation capacity. Adipogenic, osteogenic and chondrogenic differentiation capacity 
of MC1 and intra-patient control was measured in sextuplicate [adipogenesis, osteogenesis (n = 9 + 9), 
chondrogenesis (n = 8+8)]. MC1 were normalised to intra-patient control (100 %) and tested against null 
hypothesis (µ0 = 100 %) using one sample t-test. (b) Trend towards increased expression of CXCL12 and 
LEPR in MC1. CXCL12 and LEPR expression was analysed by flow cytometry. Difference in MC1 to control 
∆MFI was tested against null hypothesis (µ0 = 0) using Wilcoxon test. Single measures of MC1 and control 
were performed (n = 5 + 5). (c) Increased incidence of BMSCs in MC1. CFU-F from MC1 and control bone 
marrow mononuclear cells were fixed, stained and manually counted using Image J. Colony number 
from control bone marrow was set as 100 %. Relative MC1 colony count was calculated and tested against 
null hypothesis (µ0 = 100 %) using one sample t-test (n = 6 + 6). Single measures of MC1 and control were 
performed. *p < 0.05, **p < 0.01. 
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Table 5. Changes in the expression of BMSC surface markers. Differences (MC1-control) of MFI (∆MFI) 
with IQR in flow cytometric analysis are indicated.
Protein code Protein name
∆MFI
(MC1-control) IQR p
LEPR Leptin receptor 1395 42, 1724 0.188
CD146 Melanoma cell adhesion molecule (MCAM) − 231 − 403, 482 1.000
CD271 Low-affinity nerve growth factor receptor − 157 − 265, 1811 1.000
CXCL12 Stromal cell-derived factor 1 (SDF-1) 75 47, 217 0.063
CD54 Intercellular adhesion molecule 1 (ICAM-1) 43 − 508, 158 1.000
Nestin Nestin 1081 974, 3329 0.625
NG2 Neural/glial antigen 2 − 457 − 1313, 41 0.625
CD140a Platelet-derived growth factor receptor A (PDGFRA) − 810 − 1116, 88 0.625






COL22A1 collagen type XXII alpha 1 chain 1.545
COL4A5 collagen type IV alpha 5 chain 1.15
WNT2 Wingless-type MMTV integration site family, member 2 1.037
HAI2 Kunitz-type protease inhibitor 2 0.832
KAL1 Anosmin 1 0.826
BMP3B Bone morphogenetic protein 3B 0.822
LRRC15 Leucine rich repeat containing 15 0.794
SERPINA3 serpin family A member 3 0.792
ADAMTS16 A disintegrin and metalloproteinase with thrombospondin motifs 16 0.751
COL18A1 collagen type IIXX alpha 1 chain 0.746
PLAT Tissue plasminogen activator 0.746
COL1A1 collagen type I alpha 1 chain 0.676
FBLN2 Fibulin 2 0.656
FBLN5 Fibulin 5 0.649
GREM1 Gremlin 1 0.644
PCOLCE2 Pro-collagen C-endopeptidase enhancer 2 0.633
LAMB3 Laminin subunit beta-3 0.628
SERPINE2 Serpin peptidase inhibitor, clade E, member 2 0.612
COL4A2 collagen type IV alpha 2 chain 0.602
TNC Tenascin C − 0.638
FGFR2 Fibroblast growth factor recpetor 2 − 0.666
LUM Lumican − 0.69
CCBE1 Collagen and calcium-binding EGF domain-containing protein 1 − 0.717
TIG2 Tazarotene-induced gene 2 protein − 0.747
COL11A2 collagen type XI alpha 2 chain − 0.748
HPSE Heparanase 1 − 0.841
CHI3L1 Chitinase-3-like protein 1 − 0.867
CPXM2 Carboxypeptidase X, M14 family member 2 − 1.188
Table 6. Dysregulated genes of the GO class “extracellular matrix” (Metacore).
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TGF-β1 (Peprotech)]. Myofibroblast differentiation 
was determined based on the expression of pro-
fibrotic genes (COL1A1, ACTA2), gel contractility and 
α-SMA protein expression as described above. Effects 
of TGF-β1 stimulation was compared between MC1 
and control using paired t-test.
Assay 12: FACS of LEPRhigh MC1 and control BMSCs
MC1 and control BMSCs were stained for LEPR as 
described in assay 2. The 20 % highest expressing 
LEPR MC1 BMSCs (LEPRhigh) were sorted using 
a BD FACSAria™ Fusion. The same sorting gate 
of MC1 was applied to the intra-patient control. 
Statistical analysis of TGF-β1 effect and adipogenic 
differentiation was performed as described in assay 
3 and 11.
Statistical analysis
All statistical analyses were performed using 
GraphPad Prism version 8.4.0. An outcome was 
considered significant if p < 0.05 (p < 0.01 for RNA 
sequencing). Normal distribution was tested using 
the Shapiro Wilk test. Parametric tests were run in 
case of normal distribution and non-parametric tests 
in case of non-normal distribution.
Results
Patient characteristics
Of the 14 included patients, 3 (21.4 %) were male and 
had an average age of 67.6 ± 11.6 years. Patients were 
in average overweight (BMI: 31.4 ± 6.3 kg/m2), had a 
median VASback of 8.0, IQR = 6.0, 9.0 and a median 
VASleg of 6.5, IQR = 4.5, 8.0. ODI score was high 
(49.3 % ± 15.7 %). Bone marrow aspirates were most 
often taken from vertebral level L4 (control: n = 5; 
MC1: n = 4) and L5 (control: n = 4; MC1: n = 6). Degree 
of disc degeneration (p = 0.098; control: 5, IQR = 3, 5; 
MC1: 5, IQR = 5, 5) and total endplate score (p = 0.011; 
control: 3, IQR = 1, 4; MC1: 5, IQR = 5, 6) was higher 
at levels of MC1 than controls.
Stemness of MC1 BMSCs, expression of BMSC 
subpopulation markers and CFU-F
MSCs are defined by their expression of the 
consensus surface markers and their ability to 
differentiate into adipocytes, osteoblasts and 
chondrocytes. BMSCs from control and MC1 both 
expressed high levels of the consensus marker 
sequence without significant differences (p = 0.527; 
MC1: 93.2 % ± 4.6 %; control: 93.8 % ± 3.7 %). A 
decreased adipogenic differentiation potential of 
MC1 BMSCs compared to intra-patient control 
BMSCs (− 17.5 % ± 14.7 %, p = 0.007) was observed. 
There was no significant difference in osteoblast 
(+ 15.2 % ± 65.4 %, p = 0.505) and chondrocyte 
differentiation capacity (− 0.9 % ± 24.0 %, p = 0.915) 
(Fig. 2a).
 Flow cytometric analysis of markers describing 
BMSC subpopulations revealed no significant 
changes in expression of all tested surface markers 
(LEPR, CXCL12, CD54, CD140a, CD146, CD271, NG2, 
CD106, nestin) (Table 5). Despite the high variability, 
in all tested patients, CXCL12 was higher expressed 
in MC1 than control (p = 0.063) and LEPR was higher 
expressed in 4 out of 5 MC1 cells (p = 0.180) (Fig. 2b). 
Expression of LEPR and CXLC12 correlated (r = 0.95, 
p = 0.014). Furthermore, expression of CD271, NG2 
and CD106 correlated (r = 0.91-0.99, p = 0.001-0.031) 
as well as nestin and CD146 (r = 0.99, p = 0.002).
 To quantify the relative frequency of BMSCs 
in MC1 bone marrow, CFU-F of nucleated cells 
was quantified in MC1 and control bone marrow 
aspirates. MC1 contained more CFU-F than control 
bone marrow (+ 68.2 % ± 57.9 %, p = 0.035) (Fig. 2c).
RNA sequencing and expression of pro-fibrotic 
genes and proteins
Bulk RNA sequencing comparing MC1 to control 
BMSCs identified 219 DEGs. GO analysis of the 
DEGs with DAVID (p = 2.2 × 10− 6) and Metacore 
(p = 7.2 × 10− 13) revealed an enrichment of the ECM 
(Table 6). In the GO class “cellular components”, 
the top items were all related to ECM or collagen 
and were all up-regulated (Fig. 3a). “Extracellular 
matrix structural constituent” (p = 2.3 × 10− 6) and 
“extracellular matrix organisation” (p = 3.5 × 10− 4) 
were also the top enriched GOs in the classes 
“molecular function” and “biological process”, 
respectively. GSEA identified the Notch pathway, 
Wnt/β-catenin pathway, Hedgehog pathway and 
EMT as top enriched gene sets. Furthermore, a 
specific fibrosis gene set was highly enriched (Fig. 3b). 
GSEA of the canonical pathways gene sets derived 
from the Reactome pathway database (820 gene 
sets) and enrichment map visualisation in Cytoscape 
identified “extracellular matrix organisation” as a 
central process connected with several functions 
related to ECM formation and modification (Fig. 3c).
 Analysis of pro-fibrotic gene expression by 
qPCR revealed a slight upregulation of ACTA2 
(Log2 fold-change = 0.31 ± 0.40, p = 0.050) and of 
COL1A1 (Log2 fold-change = 0.45 ± 0.57, p = 0.046) 
as well as a marked up-regulation of MMP9 (Log2 
fold-change = 2.11 ± 1.46, p = 0.0009) in MC1 (Fig. 
3d). The increased ACTA2 expression in MC1 could 
not be confirmed on the protein level as measured 
by Western blot (p = 0.922, − 2.24 %, IQR = − 25.09 %, 
+ 22.4 %) or flow cytometry (p = 0.467, + 17.1 ± 47.6 %) 
(Fig. 3e). Concentration of pro-collagen type I alpha 1 
was significantly higher in starvation medium from 
MC1 BMSCs compared to control BMSCs (p = 0.031, 
+ 11.2 %, IQR = + 7.60 %, 22.07 %) (Fig. 3f).
Gel contraction, matrix adhesion and expression 
of FAK/p-FAK
Contraction capacities of BMSCs were quantified by 
their ability to contract collagen gels. MC1 BMSCs 
contracted collagen gels more than control BMSCs, 
resulting in smaller gels after 24 h (− 9.6 % ± 6.62 %, 
p = 0.017) (Fig. 4a).
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Fig. 3. Transcriptome profile of MC1 versus intra-patient control BMSCs. (a-c) Bulk RNA sequencing of 
in vitro-expanded MC1 and intra-patient control BMSCs (n = 4 + 4) was performed (Illumina). Genes were 
considered as DEG for p < 0.01 and Log2 fold change > ± 0.5. GO enrichment was performed in DAVID, 
GSEA with GSEA software. (a) The 10 most significantly overrepresented cellular components comparing 
MC1 to control. (b) GSEA of “hallmark” gene sets revealed enriched pro-fibrotic biological processes. (c) 
Enrichment map visualisation of pathways (Reactome database) enriched in MC1 BMSCs with gene sets 
p < 0.01, FDR q-value < 0.1 and an overlap coefficient of 0.5. Node size displays number of genes within a 
gene set, thickness of connection line represents extent of overlap between gene sets. (d) Expression of pro-
fibrotic genes was up-regulated in MC1 BMSCs. Pro-fibrotic gene expression was compared between MC1 
and control by RT-qPCR. Samples were measured in technical duplicates (n = 5 + 5 – 9 + 9) and ΔΔCq (MC1 
to control) values were tested against the null hypothesis (µ0 = 0) with one sample t-test. Log2 fold change 
of ΔΔCq are represented. (e) Representative Western blot of α-SMA expression. α-SMA protein level was 
detected by Western blot (n = 10 + 10) and band signal intensities were quantified 3 times using Image J. 
α-SMA band signal intensities were normalised to β-actin and percentages of MC1 and control intensities 
were compared with paired Wilcoxon test. (f) Synthesis of pro-collagen type I alpha 1 was increased in MC1 
BMSCs. BMSCs were cultured for 48 h in starvation medium with 1 % FCS. After medium change, medium 
was conditioned for 24 h and pro-collagen type I alpha 1 was measured by ELISA. MC1 and control were 
measured in biological duplicates and ELISA was performed in technical duplicates. *p < 0.05; **p < 0.01. 
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 Adhesion to matrix of MC1 and control BMSCs 
was compared by counting the cells that attached 
to fibronectin-coated, collagen I-coated or uncoated 
dishes. More cells bound to fibronectin-coated dishes 
(+ 7.9 % ± 11.6 %, p = 0.047) and to uncoated dishes 
(+ 9.4 % ± 12.9, p = 0.036). The increase in binding 
to type I collagen-coated dishes was not significant 
(+ 6.6 % ± 10.1, p = 0.110) (Fig. 4b).
 Whether the increased matrix adhesion was due 
to increased expression of integrins was analysed. 
There was no difference in the gene expression of all 
tested integrins except for ITGB1 (Log2 fold-change 
= 0.32 ± 0.26, p = 0.022) (Table 7). However, flow 
cytometric analysis (p = 0.871) and Western blot of 
ITGB1 (p = 0.938, + 5.31 %, IQR = − 25.9 %, + 12.7 %) 
showed no significant difference in ITGB1 protein 
level (data not shown).
 Phosphorylation of FAK is central in downstream 
signalling of integrins and is important in mediating 
cell contractility (Vallée and Lecarpentier, 2019). 
Therefore, the fraction of phosphorylated FAK to total 
FAK was measured and calculated by Western blot. 
The percentage of phosphorylated FAK from total 
FAK (p-FAK/FAK) was significantly higher in MC1 
BMSCs (+ 30.9 %, IQR = + 29.8 %, 40.7 %, p = 0.016) 
while total FAK normalised to β-actin (FAK/β-actin) 
was not increased (+ 2.8 %, IQR = − 1.1 %, 8.7 %, 
p = 0.468) (Fig. 4c,d).
Responsiveness to TGF-β1 of bulk BMSCs
The pro-fibrotic gene expression of MC1 and control 
BMSCs in response to 24 h TGF-β1 stimulation 
was compared. qPCR analysis revealed high 
interpatient variability and no increase in ACTA2 
Fig. 4. Collagen gel contractility and cell matrix adhesion. (a) MC1 BMSCs contracted gels more than the 
respective control BMSCs. MC1 and control collagen gel contractility was measured in biological duplicates. 
BMSCs were mixed with rat tail collagen I and incubated for 24 h. Gel surface area was measured using 
Image J. Size of MC1 BMSC gels was normalised to control BMSC gels (100 %) of the same patient and tested 
against null hypothesis (µ0 = 100 %) using one sample t-test. (b) Cell-matrix adhesion: increased adhesion 
of MC1 BMSCs to fibronectin and uncoated plates. BMSC adhesion to fibronectin-coated, collagen I-coated 
and uncoated (n = 8 + 8 – 11 + 11) plates were assessed between 15 and 30 min after cell seeding by counting 
adhered cells. Cell numbers were normalised to the respective 4 h counts. Percentage increase of adherent 
MC1 and control BMSCs were compared by paired t-tests. MC1 and control adhesion was measured in 
sextuplicate. (c) p-FAK was increased in MC1 BMSCs. FAK and p-FAK protein level were detected by 
Western blot (n = 7 + 7) and band signal intensities were quantified 3 times using Image J. p-FAK band signal 
intensities were normalised to total FAK (% total FAK) and percentages of MC1 and control intensities were 
compared with paired Wilcoxon test. (d) Representative Western blot of p-FAK, FAK and β-actin. *p < 0.05. 
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expression after stimulation in MC1 (Log2 fold-
change = 0.11 ± 1.61) and control (Log2 fold-change 
= − 0.25 ± 1.58) and no difference between MC1 
and control (p = 0.648). Similarly, COL1A1 (Log2 
fold-change MC1 = 0.09 ± 0.15, Log2 fold-change 
control = − 0.01 ± 0.32, p = 0.656), COL4A5 (Log2 
fold-change MC1 = 0.31 ± 0.93, Log2 fold-change 
control = − 0.11 ± 3.97, p = 0.920), FN1 (Log2 fold-
change MC1 = 0.32 ± 0.92, Log2 fold-change control 
= 0.25 ± 0.51, p = 0.900) and MMP9 (Log2 fold-
change MC1 = 3.77 ± 8.98, Log2 fold-change control 
= − 0.31 ± 2.04, p = 0.302) expression remained 
unchanged (Fig. 5a). α-SMA expression measured 
by Western blot upon TGF-β1 stimulation was not 
significantly increased in MC1 (− 0.3 % ± 75.71 %) and 
control (− 9.54 % ± 48.01 %) and did also not differ 
between MC1 and control BMSCs (p = 0.606) (Fig. 
5b). Additionally, there was no difference in collagen 
gel contraction in response to TGF-β1 in MC1 
(− 2.39% ± 15.62 %) and control (+ 12.57 % ± 14.52 %) 
and there was also no difference between MC1 and 
control BMSCs (p = 0.210).
Analysis of LEPRhigh BMSCs
To test if LEPRhigh BMSCs could undergo myofibroblast 
differentiation, α-SMA was quantified by Western 
blot after TGF-β1 stimulation of sorted LEPRhigh 
BMSCs of MC1 and control. Whereas α-SMA 
expression upon TGF-β1 stimulation in LEPRhigh 
control BMSCs was not changed (− 8.7 % ± 33.55 %, 
p = 0.693), TGF-β1 stimulation led to a strong increase 
in α-SMA expression in LEPRhigh MC1 BMSCs 
(+ 69.23 % ± 37.9 %, p = 0.035) (Fig. 5c). Furthermore, 
the adipogenic differentiation capacity of LEPRhigh 
sorted BMSCs was compared. LEPRhigh MC1 BMSCs 
of the 3 analysed patients had a trend towards 
an increased adipogenic differentiation capacity 
(+ 32.17 % ± 23.29 %, p = 0.140) (Fig. 5d).
Discussion
Bone marrow fibrosis is a pathophysiological 
important mechanism in MC1 and may have 
diagnostic and clinical relevance (Dudli et al., 2017; 
Dudli et al., 2020; Modic et al., 1988). The present 
study showed that BMSCs in MC1 have a pro-
fibrotic phenotype compared to BMSCs from control 
vertebral bone marrow from the same patient. This 
phenotype is characterised by excessive production 
of ECM, increased cell contraction capability and 
enhanced adhesion. Increased FAK phosphorylation 
was identified as an important fibrotic characteristic 
of MC1 BMSCs, suggesting a mechanistical link 
between increased cell adhesion and cell contractility. 
An overrepresented LEPRhigh subpopulation in 
MC1 but not control could undergo myofibroblast 
differentiation and, hence, be a possible driver of 
fibrosis in MC1.
Increased CFU-F and LEPR expression and reduced 
adipogenic differentiation capacity in MC1
BMSCs are a heterogeneous population of fibroblastic 
cells. Sub-populations of BMSCs are responsible for 
bone marrow fibrosis in other conditions (Decker et 
al., 2017; Schneider et al., 2017). Whether the BMSC 
population in MC1 was different from the control 
BMSC population of the adjacent vertebra was 
investigated. CD14−, CD19−, CD34−, CD45−, CD73+, 
CD90+ and CD105+ marker expression was compared. 
Even though these markers are indistinguishably 
expressed on fibroblasts and MSCs, this surface 
marker expression combination is an important 
criterion that defines MSCs (Denu et al., 2016; Dominici 
et al., 2006). MC1 and control BMSCs did not differ in 
the expression of the MSC consensus markers CD14−, 
CD19−, CD34−, CD45−, CD73+, CD90+ and CD105+ but 
MC1 BMSCs tended to express more CXCL12 and 
LEPR with correlating expression of CXCL12 and 
LEPR. Despite the high patient variability in absolute 
expression levels, these findings were consistent and 
may indicate that a CXCL12+ LEPR+ population was 
overrepresented in MC1. CXCL12+ LEPR+ cells are 
a perisinusoidal population that create a niche for 
haematopoietic stem cells and give rise to osteoblasts 
(Acar et al., 2015; Galán-Díez and Kousteni, 2018). 
Neovascularisation in MC1 may go along with 
expansion of a CXCL12+ LEPR+ population on the 
newly formed sinusoidal surface (Bailey et al., 2011). 
Increased number of CFU-F in MC1 could support 
this notion as almost all CFU-F are LEPR+ BMSCs 
(Decker et al., 2017; Zhou et al., 2014). Expansion of 
CXCL12+ LEPR+ cells could be a response to endplate 
and trabecular bone damage in MC1 because LEPR+ 
Table 7. Gene expression analysis of integrin 
subunits. Mean and SD of Log2 fold change (Log2fc) 






ITGA1 0.120 0.605 0.586
ITGA2 0.100 0.520 0.609
ITGA3 − 0.340 1.179 0.447
ITGA4 0.000 0.768 0.989
ITGA5 0.130 0.616 0.561
ITGA6 − 0.350 0.897 0.306
ITGA7 0.080 1.087 0.832
ITGA8 0.908 2.047 0.450
ITGA10 0.347 0.769 0.243
ITGA11 0.170 0.704 0.514
ITGAV 0.225 0.466 0.215
ITGB1 0.290 0.306 0.022*
ITGB2 − 0.010 1.404 0.984
ITGB3 − 0.041 0.395 0.779
ITGB5 − 0.018 0.419 0.906
ITGB8 − 0.150 0.939 0.661
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BMSCs proliferate after bone injury and give rise to 
osteoblasts (Galán-Díez and Kousteni, 2018; Zhou 
et al., 2014). Importantly, CXCL12+ LEPR+ cells have 
been identified as a major source of myofibroblasts 
in bone marrow fibrosis in primary myelofibrosis 
(Decker et al., 2017). Although primary myelofibrosis 
is a distinct pathological entity, the study by Decker 
et al. (2017) showed that CXCL12+ LEPR+ cells are 
capable of undergoing myofibroblast differentiation 
and contribute to bone marrow fibrosis.
 LEPR-expressing BMSCs are the main progenitor 
cells that generate adipocytes, osteoblasts and 
chondrocytes in the bone marrow (Zhou et al., 2014). 
Differentiation of BMSCs in MC1 may be affected by 
the inflammatory environment (Huang et al., 2014), 
bony endplate damages (Zhou et al., 2014) and pro-
osteoclastic/anti-osteoblastic factors draining from 
the adjacent intervertebral discs through endplate 
damages into the bone marrow (Dudli et al., 2017; 
Rajasekaran et al., 2004; Torkki et al., 2016). In 
this complex environment, a reduced adipogenic 
differentiation capacity but no significant difference 
in osteogenic and chondrogenic differentiation 
were found. This indicated a net loss of the tri-
lineage differentiation capacity and stemness and 
suggested an unspecific fibroblastic polarisation of 
MC1 BMSCs. A loss of adipogenic differentiation 
capacity of fibroblasts has also been shown in a 
bleomycin-induced mouse model of fibrosis (El 
Agha et al., 2017b). Lung fibroblasts underwent a 
shift away from adipogenic towards myofibroblasts 
polarisation, while resolution of fibrosis reversed the 
shift. However, the present study results indicated 
that LEPRhigh BMSCs did not contribute to the reduced 
adipogenic differentiation capacity. In contrast, 
LEPRhigh BMSCs in MC1 tended to differentiate more 
into adipocytes than LEPRhigh BMSCs of controls. This 
corresponded with the finding of Yue et al. (2016) 
Fig. 5. MC1 and control BMSCs in response to TGF-β1. (a) TGF-β1 stimulation did not result in a different 
pro-fibrotic gene expression between MC1 and control BMSCs. Gene expression of 24 h stimulation 
with 10 ng/mL TGF-β1 was measured by RT-qPCR (n = 5 + 5) in technical duplicates. Effects of TGF-β1 
stimulation was compared between MC1 and control by paired t-test. (b) No difference in α-SMA protein 
level upon TGF-β1 stimulation in MC1 and control BMSCs. α-SMA protein level of TGF-β1-stimulated and 
-unstimulated MC1 and control BMSCs was detected by Western blot (n = 5 + 5). Band signal intensities were 
quantified 3 times using Image J. Effects of TGF-β1 stimulation were compared by paired t-test. (c) TGF-β1 
stimulation of LEPRhigh-sorted MC1 BMSCs resulted in a significant increase in α-SMA production, whereas 
there was no change in LEPRhigh-sorted control BMSCs. α-SMA protein level in TGF-β1-stimulated and 
-unstimulated LEPRhigh-sorted MC1 (n = 4) and control BMSCs (n = 3) was detected by Western blot. Band 
signal intensities were quantified 3 times using Image J. Effects of TGF-β1 stimulation were compared by 
paired t-test. (d) LEPRhigh MC1 BMSCs had a trend towards increased adipogenic differentiation capacity. 
Adipogenic differentiation capacity of LEPRhigh-sorted MC1 and intra-patient control was measured in 
sextuplicate (n = 3 + 3). LEPRhigh MC1 was normalised to intra-patient LEPRhigh control (100 %) and tested 
against null hypothesis (µ0 = 100 %) using one sample t-test. Log2fc: Log2 fold-change.*p < 0.05.
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who showed that leptin receptor on mesenchymal 
stromal cells promotes adipogenesis. The present 
study findings suggested that the reduced adipogenic 
differentiation capacity of “bulk” MC1 BMSCs was 
caused by the LEPRlow BMSC population and that 
a myofibroblastic BMSC phenotype was rather 
linked to increased adipogenesis than reduced 
adipogenesis. The underlying mechanisms for the 
altered adipogenic differentiation capacities in 
LEPRhigh and LEPRlow remain unknown.
 Together, these findings suggested that a 
perivascular population was overrepresented in 
MC1 and that MC1 BMSC differentiation capacity 
was reduced. The reduced adipogenic differentiation 
capacity could most likely not be attributed to the 
overrepresented LEPRhigh population in MC1 BMSCs. 
It needs to be shown if the over represented population 
and the reduced adipogenic differentiation potential 
of MC1 BMSCs were causally linked to fibrosis in 
MC1.
Pro-fibrotic ECM production and signalling in MC1 
BMSCs
The transcriptome of MC1 BMSCs showed a pro-
fibrotic phenotype of MC1 BMSCs, with increased 
ECM deposition and activation of pro-fibrotic 
signalling pathways. ECM constituents and modifying 
enzymes were enriched in GO analysis and were the 
most enriched gene sets in the pathway analysis. 
Increased synthesis of ECM is a hallmark of fibrosis 
and is causally linked to clinical manifestations in 
many fibrotic pathologies as it restricts proper tissue 
function (Wynn, 2008). Synthesis of pro-collagen type 
I alpha 1, the prototypical ECM constituent secreted 
by myofibroblasts, was increased in MC1 BMSCs 
and type XXII collagen alpha 1 and type IV collagen 
alpha 5 were the top dysregulated ECM constituents 
of the MC1 BMSC transcriptome. Type XXII collagen 
has been identified as a marker of the transition 
of skin fibroblasts to myofibroblasts in systemic 
sclerosis (Watanabe et al., 2019). Type IV collagen 
is a prototypic ECM protein of myofibroblasts and 
pro-collagen type IV turnover has been identified as 
a prognostic marker for the disease progression of 
systemic sclerosis [Dobrota et al. (2020). Circulating 
collagen turnover markers are specifically changed 
in very early systemic sclerosis. Ann Rheum Dis 
79: 159; conference abstract; Klingberg et al., 2013]. 
Importantly, circulating pro-collagen type IV has 
been reported to be increased in peripheral blood 
of MC1 patients (Dudli et al., 2020). This shows 
that increased ECM secretion through fibrotic 
mechanisms in MC1 has a potential diagnostic 
value. Findings suggested a link between increased 
serum values of type IV collagen and the fibrotic 
pathomechanism in MC1 bone marrow. If this can 
be validated, it is an important finding as it provides 
face validity for circulating pro-collagen-4 as MC1 
biomarker and underscores the clinical significance 
of bone marrow fibrosis in MC1.
 Besides increased ECM secretion, fibrosis and 
EMT were identified, as well as the three signalling 
pathways, Notch, Wnt/β-catenin and Hedgehog as 
the top enriched gene sets in MC1. This corroborated 
the pro-fibrotic phenotype of MC1 BMSCs as all three 
signalling pathways mediated fibrotic processes 
across different organs and tissues, including lung, 
kidney, skin, liver and heart (Burgy and Königshoff, 
2018; Hu et al., 2015; Hu and Phan, 2016; Lam and 
Gottardi, 2011). Inhibition of Notch, Wnt/β-catenin 
and Hedgehog signalling inhibits tissue fibrosis 
through mechanisms that inhibit EMT (Fontaine et 
al., 2008; Wang et al., 2019; Yuan et al., 2016). Notch 
signalling also promotes PMT, which could explain 
the increase in the pericyte-like CXCL12+ LEPR+ 
population. Furthermore, Notch, Wnt/β-catenin 
and Hedgehog signalling affect MSC differentiation. 
Notch signalling generally inhibits any lineage 
differentiation but enhances MSC proliferation (Dong 
et al., 2010). Hedgehog and Wnt/β-catenin signalling 
promote osteoblast differentiation and inhibit 
adipocyte differentiation (Fontaine et al., 2008; Yuan et 
al., 2016). Therefore, increased Notch, Wnt/β-catenin 
and Hedgehog signalling may relate to increased 
CFU-F and decreased adipogenic differentiation 
capacity as found in the present study.
Increased cell adhesion, cell contractility and FAK 
phosphorylation
Phosphorylation of FAK has been identified as 
an important mechanism in fibroblasts causing 
bone marrow fibrosis and lung fibrosis (Desterke 
et al., 2015; Lagares et al., 2012; Zhao et al., 2016). 
Increased matrix adhesion, gel contractility and FAK 
phosphorylation were found in MC1 BMSCs. This 
was a strong indication for a pro-fibrotic phenotype 
of MC1 BMSCs and that FAK was important in MC1 
fibrosis.
 FAK is a key kinase of the ECM-cytoskeleton 
mechanotransduction via integrins and mediates 
several fibrotic mechanisms. FAK modulates 
adhesion strength through integrin activation 
and modulates cell contractility by α-SMA and 
actin polymerisation at focal adhesions (Michael 
et al., 2009). Phosphorylation of FAK occurs after 
integrin binding to matrix and is associated with the 
cytoplasmic domain of integrin β subunits. Integrins 
are αβ-heterodimers and, of the β-subunits, integrin 
β1 conveys a key role as it binds almost all α-subunits 
to form matrix receptors. The α-subunit defines the 
specificity of the integrin receptor to bind fibronectin, 
collagen or laminin. In fibrosis, integrin β1 plays 
a central role and its inhibition or knock-down 
reduces fibrosis (Basta et al., 2020; Liu et al., 2009; 
Zhao et al., 2016). MC1 BMSCs adhered stronger to 
fibronectin and uncoated plastic dishes, indicating 
an increased non-specific matrix binding. Next, it 
was assessed whether increased non-specific binding 
was caused by overexpression of specific integrins 
and in particular of the universal subunit integrin 
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β1. No change in gene transcription of 16 tested 
integrin subunits was found, except for integrin β1, 
which was marginally but significantly upregulated. 
However, increased integrin β1 expression could 
not be validated at protein level by Western blot and 
flow cytometric analysis. Matrix adhesion is also 
modulated by FAK through ‘inside-out’ signalling 
that activates integrins through conformational 
changes (Michael et al., 2009). Therefore, increased 
matrix adhesion in MC1 BMSCs was not due to 
overexpression of integrins but might be due to FAK 
phosphorylation through other pathways.
 Phosphorylation of FAK is important for the 
formation of α-SMA stress fibres that mediate 
cell contractility. MC1 BMSCs had an increased 
cell contractility without a relevant increase in 
α-SMA expression. This suggested a mechanism 
independent of α-SMA expression. Organisation 
and polymerisation of actin is FAK-mediated and 
an important early step in the formation of focal 
adhesion that transduce mechanical forces. It might 
be that MC1 BMSCs had a more efficient way to 
form nascent adhesions and increase cell contractility 
without increasing α-SMA expression.
Responsiveness to myofibroblast differentiation
Myofibroblasts are α-SMA-expressing highly 
contractile cells that produce large amounts of ECM. 
TGF-β1 is a master regulator of fibrosis and promotes 
myofibroblast differentiation (Van Caam et al., 
2018). No difference in pro-fibrotic gene expression, 
α-SMA production and collagen gel contraction 
were found between MC1 and control BMSCs in 
response to TGF-β1. As Decker et al. (2017) identified 
LEPR-expressing BMSCs as the cellular origin of the 
collagen-producing myofibroblasts in bone marrow 
fibrosis, it was investigated whether TGF-β1 induced 
myofibroblast differentiation of LEPRhigh BMSCs. 
Interestingly, LEPRhigh-sorted MC1 BMSCs had a 
significantly upregulated α-SMA production upon 
TGF-β1 stimulation, whereas LEPRhigh-sorted control 
BMSCs had not. These results showed two things. 
First, that a LEPRhigh subpopulation of MC1 BMSCs 
could undergo myofibroblast differentiation, which 
corresponds to the bone marrow fibrosis contributing 
CXCL12+ LEPR+ phenotype discovered by Decker 
et al. (2017). Second, since LEPRhigh control BMSCs 
did not undergo TGF-β1-induced myofibroblast 
differentiation, LEPR expression on BMSCs was not 
a sufficient criterion for myofibroblast differentiation. 
Therefore, MC1 LEPRhigh BMSCs but not control 
LEPRhigh BMSCs were susceptible to differentiate into 
myofibroblasts. It remains unknown what makes 
MC1 LEPRhigh BMSCs susceptible to myofibroblast 
differentiation, yet chronic inflammation as well as 
biomechanical changes within MC1 bone marrow 
might be critical factors.
 In summary, while collectively BMSCs in MC1 
had a pro-fibrotic phenotype, only a LEPRhigh BMSC 
population in MC1 could undergo myofibroblast 
differentiation. The role of the different BMSC 
subpopulations in the fibrotic pathomechanism 
of MC1 awaits investigations. It also needs to be 
demonstrated if MC1 bone marrow indeed contains 
α-SMA positive myofibroblasts.
Limitations and critical evaluation
BMSCs from patients with lumbar MC1 who 
underwent lumbar spinal fusion were investigated. 
Since LBP is a multifactorial disease and MC1 is 
not an indication for surgery, patients had different 
surgical indications. Most suffered from spinal 
stenosis, listhesis, scoliosis, sagittal misalignment 
or facet joint degeneration at the surgical level. 
Hence, different aetiologies may have caused MC1. 
However, mechanical overload and endplate damage 
always occur in MC1 and seem to be independent of 
the primary diagnosis (Dudli et al., 2016). Therefore, 
pathophysiological bone marrow changes in MC1 
may be less diverse than their aetiology. Nevertheless, 
to select patients with mainly axial and not radicular 
pain, only patients with higher VAS scores for back 
pain than leg pain were enrolled. Also, patients with 
prior spinal fusion, malignancies and infectious 
disease were excluded to eliminate potential 
confounders.
 Size and type of MC1 (pure MC1 vs. mixed MC1/
MC2) may also affect BMSC phenotype. Only BMSCs 
from MC lesions that were classified as MC1 or mixed 
MC1/MC2 were investigated. Pure MC1 are rare, in 
particular in patients undergoing spinal fusion, as 
this is the treatment of last resort and MC1 at the time 
of operation may have evolved over time through 
different phases of MC1 and MC2 before.
 The quality of the aspirate may affect the 
investigated BMSC population. Intraoperative 
X-ray confirmed that the bone marrow aspiration 
needle was placed at the correct site before taking 
the aspirate. However, it was not possible to monitor 
the marrow space which was aspirated. Therefore, it 
was not possible to validate post-operatively if MC1 
aspirate contained cells only from MC1 lesions or if 
cells from non-affected areas were aspirated as well. 
Control bone marrow is heterogeneous as well and 
often shows small areas of signal intensity changes 
related to focal changes in marrow composition. 
Therefore, aspirates from control marrow may have 
also contained some potential pathological cells. 
The aspiration volume was limited to maximal 
3.5 mL. This volume limits the risk of aspirating 
peripheral blood and bone marrow cells outside the 
target area (Brooimans et al., 2009) and at the same 
time guarantees a large enough cell pool to obtain a 
representative population from the target area.
 Culturing BMSCs changes their expression 
profile (Ghazanfari et al., 2017). However, a thorough 
characterisation of primary BMSCs is not possible 
because primary BMSCs are a rare population in 
bone marrow and not enough cells would have been 
available for all assays. MC1 are a chronic condition 
and many changes are likely stably imprinted and 
do not change during expansion. Therefore, cells 
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from MC1 and control were expanded in vitro and 
always used at the same passage (passage 3, 4 or 5) 
to minimise any culture expansion effects.
 It was not possible to correlate changes across 
different assays as not all were performed with cells 
from the same patient. This limits a more powerful 
interpretation of the data as patient-to-patient 
variation was considerable for most assays. However, 
MC1 BMSCs were always compared to intra-patient 
control BMSCs for each assay, which eliminated 
most of patient-related confounders and allowed for 
a paired analysis.
Conclusion
In summary, the present is the first study 
characterising BMSCs in MC1. Important pro-
fibrotic changes in MC1 BMSC and a LEPRhigh MC1 
BMSC subpopulation susceptible to myofibroblast 
differentiation were found. Fibrosis is a hallmark 
of MC1 and BMSCs in MC1 represent a potential 
therapeutic target to control fibrosis in MC1. A causal 
link between the pro-fibrotic phenotype and clinical 
characteristics needs to be demonstrated.
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Reviewer: Cells from an adjacent level have been 
used as a matched control group. Is there a possibility 
that BMSCs from the control group might have been 
affected by a crosstalk with MC1 cells?
Authors: The reviewer points out an important point. 
The bone marrow is not an isolated organ and stands 
in physical and biological exchange with surrounding 
tissues. Nevertheless, MC are separated from healthy 
bone marrow with a clear demarcation line, as 
already pointed out by Michael Modic’s original 
study (Modic et al., 1988). Therefore, diseased tissue 
and healthy tissue can clearly be distinguished. While 
paracrine communication may occur and affect BMSC 
phenotype, the local environment of control and 
MC1 bone marrow are decisive. This results in MC1 
and control BMSC phenotypes that show relevant 
differences, as shown in the present study.
Elena Della Bella: MSCs are frequently suggested 
and used in clinical trials for the treatment of low-
back pain and disc-related disorders. If confirmed that 
BMSCs contribute substantially to MC1 changes, do 
the authors think that this might be a contraindication 
for possible therapeutic use of MSCs in patients with 
MC1 lesions?
Authors: This is a great question. The past and 
ongoing clinical trials using MSCs to regenerate 
degenerated discs did not stratify for patients with 
MC. In contrast, some of them explicitly excluded 
them, possibly to reduce patient heterogeneity. 
Therefore, no data is available that shows the effect 
of MC on disc regeneration studies.
 We personally do not think that MC in the adjacent 
bone marrow are a contraindication. In contrast, the 
immunomodulatory effect of MSCs could be critical 
to break the pro-inflammatory and pro-fibrotic 
crosstalk of discs and bone marrow at levels with 
MC (Dudli et al., 2017). However, a contraindication 
is more likely the advanced stage of disc degeneration 
that typically is present at levels with MC. Disc 
regeneration studies generally aim at regenerating a 
moderately degenerated disc. Late stage degenerated 
discs might not be ideal for regeneration studies.
Editor’s note: The Scientific Editor responsible for 
this paper was Sibylle Grad.
